Electrocochleography (ECoG) has historically been used for measuring hearing thresholds and identifying endolymphatic hydrops in Ménière’s disease. More recently, ECoG application has expanded to monitor electrical potentials during cochlear implantation as an indirect measure of cochlear trauma.
Although functional outcome expectations are similar between candidates who elect to receive or forgo cochlear implants, the latter have higher baseline CI-specific quality of life abilities.
Findings suggest that cancer survivors have a significantly higher prevalence of both audiometry-confirmed and self-reported hearing loss than the general population.
Randomized controlled trials with standardized hyperbaric oxygen therapy treatment protocols and attention to social determinants of health and other confounders are desperately needed to establish efficacy.
A potential solution for lack of cadaveric temoral bone has been the use of virtual or 3D-printed temporal bones to simulate the drilling exercise and provide specimens to teach anatomy and procedures.
This two-stage surgical auricle reconstruction is a versatile, reliable, and effective congenital microtia treatment.
Patients presenting with aural discomfort are commonly encountered in otolaryngology. Part of the challenge in diagnosing these patients is the variability in their descriptions of the location, severity, and quality of aural discomfort.
There was a higher risk of a new tinnitus diagnosis after influenza, Tdap, and pneumococcal vaccinations than after the COVID-19 vaccine.
Middle cranial fossa and transmastoid approaches to superior semicircular canal dehiscence repair are effective approaches that result in acceptable rates of favorable hearing outcomes for patients.
Patients with a diagnosis of trisomy 13 or 18 often require multidisciplinary management, and the range of care spans the breadth of otolaryngology. Although T13 and T18 are considered mostly universally fatal, improvements in cardiac surgery have increased survival rates.